Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases
- PMID: 11818324
- DOI: 10.1164/ajrccm.165.3.2107134
Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases
Abstract
KL-6, surfactant protein (SP)-A, SP-D, and monocyte chemoattractant protein-1 (MCP-1) are reported to be sensitive markers for interstitial lung diseases (ILD). However, each marker has been studied independently. The aim of this study was a comparative analysis of the diagnostic values of these markers. Subjects consisted of 33 patients with ILD (21 cases of idiopathic pulmonary fibrosis and 12 associated with collagen vascular diseases) and 82 control subjects (12 cases of bacterial pneumonia and 70 healthy volunteers). Receiver operating characteristic curves revealed that KL-6 was superior to the other markers. The cut-off levels for these markers that resulted in the highest diagnostic accuracy were determined to be 465 U/ml for KL-6, 48.2 ng/ml for SP-A, 116 ng/ml for SP-D, and 1080 pg/ml for MCP-1. The sensitivity, specificity, and diagnostic accuracy were 93.9%, 96.3%, and 95.7% for KL-6; 81.8%, 86.6%, and 85.2% for SP-A; 69.7%, 95.1%, and 87.8% for SP-D; and 51.5%, 92.7%, and 80.9% for MCP-1; respectively. The serum levels of SP-A and SP-D, but not of KL-6, were significantly higher in patients with bacterial pneumonia than in healthy volunteers. These results suggest that of the markers studied, KL-6 is the best serum marker for ILD.
Similar articles
-
[The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases].Rinsho Byori. 2000 Jun;48(6):554-60. Rinsho Byori. 2000. PMID: 10897675 Clinical Trial. Japanese.
-
[Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].Ryumachi. 2003 Feb;43(1):19-28. Ryumachi. 2003. PMID: 12692986 Japanese.
-
[New serum markers to monitor treatment of acute exacerbation of interstitial lung disease].Nihon Kokyuki Gakkai Zasshi. 2001 Apr;39(4):298-302. Nihon Kokyuki Gakkai Zasshi. 2001. PMID: 11481832 Japanese.
-
[Surfactant proteins A and D as biomarkers of disease activity in diffuse interstitial pneumonia].Nihon Kokyuki Gakkai Zasshi. 2000 Mar;38(3):157-65. Nihon Kokyuki Gakkai Zasshi. 2000. PMID: 10846395 Review. Japanese.
-
[Clinical usefulness of KL-6 as a serum marker of idiopathic interstitial pneumonia].Nihon Kyobu Shikkan Gakkai Zasshi. 1996 Dec;34 Suppl:186-9. Nihon Kyobu Shikkan Gakkai Zasshi. 1996. PMID: 9216213 Review. Japanese.
Cited by
-
Identification and characterization of lysophosphatidylcholine 14:0 as a biomarker for drug-induced lung disease.Sci Rep. 2022 Nov 17;12(1):19819. doi: 10.1038/s41598-022-24406-z. Sci Rep. 2022. PMID: 36396675 Free PMC article.
-
Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation.Transl Res. 2012 Dec;160(6):435-42. doi: 10.1016/j.trsl.2012.08.003. Epub 2012 Sep 16. Transl Res. 2012. PMID: 22989614 Free PMC article.
-
Plasma levels of surfactant protein D and KL-6 for evaluation of lung injury in critically ill mechanically ventilated patients.BMC Pulm Med. 2010 Feb 16;10:6. doi: 10.1186/1471-2466-10-6. BMC Pulm Med. 2010. PMID: 20158912 Free PMC article.
-
Mammalian Neuraminidases in Immune-Mediated Diseases: Mucins and Beyond.Front Immunol. 2022 Apr 11;13:883079. doi: 10.3389/fimmu.2022.883079. eCollection 2022. Front Immunol. 2022. PMID: 35479093 Free PMC article.
-
Ageing and long-term smoking affects KL-6 levels in the lung, induced sputum and plasma.BMC Pulm Med. 2011 May 11;11:22. doi: 10.1186/1471-2466-11-22. BMC Pulm Med. 2011. PMID: 21569324 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous